Protective effect of sitagliptin against renal ischemia reperfusion injury in rats

Renal Failure

Volumn 37, Issue 4, 2015, Pages 687-693

  Nuransoy, Ayse ^a   Beytur, Ali ^a   Polat, Alaadin ^a   Samdanci, Emine ^a   Sagir, Mustafa ^a   Parlakpinar, Hakan ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Ischemia reperfusion injury; Kidney; Oxidative stress; Rat; Sitagliptin

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SITAGLIPTIN; SUPEROXIDE DISMUTASE; DIPEPTIDYL PEPTIDASE IV INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; KIDNEY ISCHEMIA; LIPID PEROXIDATION; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; REPERFUSION INJURY; SHAM PROCEDURE; UREA NITROGEN BLOOD LEVEL; ANIMAL; DISEASE MODEL; KIDNEY; RANDOMIZATION; VASCULARIZATION; WISTAR RAT;

ANIMALS; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DISEASE MODELS, ANIMAL; FEMALE; KIDNEY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REPERFUSION INJURY; SITAGLIPTIN PHOSPHATE;

EID: 84930334989     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2015.1010991     Document Type: Article

References (56)

1. Lin Y, Manning PT, Jia J, et al. CD47 blockade reduces ischemiareperfusion injury and improves outcomes in a rat kidney transplant model. Transplantation. 2014;98(4):394-401.
2. Gao Y, Chen L, Ning Y, et al. Hydro-Jet-Assisted laparoscopic partial nephrectomy with no renal arterial clamping: A preliminary study in a single center. Int Urol Nephrol. 2014; 46(7):1289-1293.
3. Landry GJ, Lau IH, Liem T, et al. Adjunctive renal artery revascularization during juxtarenal and suprarenal abdominal aortic aneurysm repairs. Am J Surg. 2010;199:641-645.
4. Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273:4135-4142.
5. Stravodimos KG, Koritsiadis G, Lazaris AC, et al. Hydronephrosis promotes expression of hypoxia-inducible factor 1 alpha. Urol Int. 2009;82(1):38-42.
6. Yamamoto S, Hagiwara S, Hidaka S, et al. The anti-oxidant EPC-K1 attenuates renal ischemia-reperfusion injury in a rat model. Am J Nephrol. 2011;33:485-490.
7. Mohamed Ael H, Lasheen NN. Comparative study on the protective role of vitamin C and L-Arginine in experimental renal ischemia reperfusion in adult rats. Int J Physiol Pathophysiol Pharmacol. 2014;6(3):153-165.
8. Paller MS. Acute renal failure: Controversies, clinical trials, and future. Semin Nephrol. 1998;18:482.
9. Akcetin Z, Busch A, Kessler G, et al. Evidence for only a moderate lipid peroxidation during ischemia-reperfusion of rat kidney due to its high antioxidative capacity. Urol Res. 1999;27:280-284.
10. Defraigne JO, Detry O, Pincemail J, et al. Direct evidence of free radical production after ischemia and reperfusion and protective effect of desferrioxamine: ESR and vitamin E studies. Eur J Vasc Surg. 1994;8:537-543.
11. Reiter RJ, Guerrero JM, Garcia JJ, et al. Reactive oxygen intermediates molecular damage and aging. Relation to melatonin. Ann NY Acad Sci. 1998;854:410-424.
12. Deacon CF, Hughes TE, Holst JJ, et al. Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes. 1998;47:764-769.
13. White JR. Dipeptidyl peptidase-IV inhibitors: Pharmacological profile and clinical use. Clin Diabetes. 2008;26(2):53-57.
14. Redondo A, Trigo MV, Acitores A, et al. Cell signalling of the GLP-1 action in rat liver. Mol Cell Endocrinol. 2003;204: 43-50.
15. Wei Y, Mojsov S. Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett. 1995;358: 219-224.
16. Vila Petroff MG, Egan JM, Wang X, et al. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res. 2001;89:445-452.
17. Bose AK, Mocanu MM, Carr RD, et al. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes. 2005;54:146-151.
18. Colak C, Parlakpinar H. Animals in research: reporting in vivo experiments: ARRIVE guidelines-Review. J Turgut Ozal Med Cent. 2012;19(2):128-131.
19. Vaghasiya J, Sheth N, Bhalodia Y, et al. Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes. Regul Pept. 2011;166(1-3):48-54.
20. Tasdemir C, Tasdemir S, Vardi N, et al. Protective effect of infliximab on ischemia/reperfusion-induced damage in rat kidney. Renal Failure. 2012;34(9):1144-1149.
21. Altintas R, Parlakpinar H, Beytur A, et al. Protective effect of dexpanthenol on ischemia-reperfusion-induced renal injury in rats. Kidney Blood Press Res. 2012;36(1):220-230.
22. Uchiyama M, Mihara M. Determination of MDA precursor in tissue by TBA test. Anal Biochem. 1978;36:271-278.
23. Sun USY, Oberley LW, Li Y, et al. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34: 497-500.
24. Aebi H. Catalase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. New York: Academic Press; 1974:673-677.
25. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-170.
26. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82:70-77.
27. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004;37:277-285.
28. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103-1111.
29. Karaman A, Turkmen E, Gursul C, et al. Prevention of renal ischemia/reperfusion-induced injury in rats by leflunomide. Int J Urol. 2006;13(11):1434-1441.
30. Altintas R, Polat A, Vardi N, et al. The protective effects of apocynin on kidney damage caused by renal ischemia/reperfusion. Exp Endourolog. 2013;27:617-624.
31. de Groot H, Rauen U. Ischemia-reperfusion injury: Processes in pathogenetic networks: A review. Transplant Proc. 2007;39: 481-484.
32. Sheridan AM, Bonventre JV. Pathophysiology of ischemic acute renal failure. Contrib Nephrol. 2001;32:7-21.
33. Chatterjee PK. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: A comprehensive review. Naunyn Schmiedebergs Arch Pharmacol. 2007;376:1-43.
34. Landry GJ, Lau IH, Liem T, et al. Adjunctive renal artery revascularization during juxta renal and suprarenal abdominal aortic aneurysm repairs. Am J Surg. 2010;199:641-645.
35. Holmberg SR, Cumming DV, Kusoma Y, et al. Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. Cardioscience. 1991;2: 19-25.
36. Kurcer Z, Parlakpinar H, Vardi N, et al. Protective effects of chronic melatonin treatment against renal ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes. 2007;115(6):365-371.
37. Weight SC, Bell PRF, Nicholson ML, et al. Renal ischemiareperfusion injury. Br J Surg. 1996;83:162-170.
38. Locatelli F, Pozzoni P, Del Vecchio L, et al. Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol. 2004;15:S25-S29.
39. Erdogan H, Fadillioglu E, Yagmurca M, et al. Protein oxidation and lipid peroxidation after renal ischemia reperfusion injury: Protective effects of erdosteine and N-Acetylcysteine. Urol Res. 2006;34:41-46.
40. Hayes JD, McLellan LI. Glutathione and glutathione dependent enzymes represent a coordinately regulated defence against oxidative stress. Free Radic Res. 1999;31:273-300.
41. Lien YH, Lai LW, Silva AL, et al. Pathogenesis of renal ischemia/ reperfusion injury: Lessons from knockout mice. Life Sci. 2003;74: 543-552.
42. Filho DW, Torres MA, Bordin AL, et al. Spermatic cord torsion, reactive oxygen and nitrogen species and ischemia-reperfusion injury. Mol Aspects Med. 2004;25:199-210.
43. Nauck MA Heimesaat MM, Behle K, et al. Effects of glucagonlike-peptide1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab. 2002;87:1239-1246.
44. Urosova IA, Farilla L, Hui H, et al. GLP-1 inhibition of pancreatic islet cell apoptosis. Trends Endocrininol Metab. 2004; 15:27-33.
45. Li Y, Hansotia T, Yusta B, et al. Glucagon-like-peptide 1 receptor signaling modulates beta cell apoptosis. J Biol Chem. 2003;278: 471-478.
46. Wang WJ, Chang CH, Sun MF, et al. DPP-4 Inhibitor attenuates toxic effects of indoxyl sulfate on kidney tubular cells. PLoS One. 2014;9(4):e93447.
47. Joo KW, Kim S, Ahn S, et al. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney. BMC Nephrology. 2013;14:98.
48. Ozdemir R, Parlakpinar H, Polat A, et al. Selective endothelin A (ET A) receptor antagonist (BQ 123) reduces both myocardial infarct size and oxidant injury. Toxicology. 2006;219:142-149.
49. Sahna E, Parlakpinar H, Ozturk F, et al. The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res. 2003;3: 188-193.
50. Parlakpinar H, Olmez E, Acet A, et al. Beneficial effects of apricotfeeding on myocardial ischemia-reperfusion injury in rats. Food Chem Toxicol. 2009;49:802-808.
51. Walker EM, Gale GR. Methods of reduction of cisplatin nephrotoxicity. Ann Clin Lab Sci. 1981;11:397-410.
52. Singh I, Gulati S, Orak JK, et al. Expression of antioxidant enzymes in rat kidney during ischemia-reperfusion injury. Mol Cell Biochem. 1993;125:97-104.
53. Erdogan H, Fadillioglu E, Yagmurca M, et al. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: Protective effects of erdosteine and N-Acetylcysteine. Urol Res. 2006;34:41-46.
54. Tenorio-Velazquez VM, Barrera D, Franco M, et al. Hypothyroidism attenuates protein tyrosine nitration, oxidative stress and renal damage induced by ischemia and reperfusion: Effect unrelated to antioxidant enzymes activities. BMC Nephrol. 2005;6:12.
55. Parlakpinar H, Tasdemir S, Polat A, et al. Protective role of caffeic acid phenethyl ester (CAPE) on gentamicin-induced acute renal toxicity in rats. Toxicology. 2005;207:169-177.
56. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 2003;14: 2199-2210.